Nippon India Pharma Fund Direct IDCW
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct IDCW
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 9166.4
Nippon India Pharma Fund Direct IDCW - Nav Details
Nav Date
: 11-Nov-2026
NAV [Rs.]
: 181.4824
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct IDCW- NAV Chart
Nippon India Pharma Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 3.82 | 8.41 | 2.42 | 9.74 | 16.22 | 18.69 | 15.43 | 18.11 |
| Category Avg | 3.26 | 0.81 | -0.82 | 13.6 | 13.38 | 21.22 | 14.97 | 15.6 |
| Category Best | 4.63 | 2.27 | 1.97 | 20.46 | 23.76 | 30.62 | 19.12 | 29.58 |
| Category Worst | 2.52 | -0.67 | -5.05 | 3.32 | -0.34 | 15.91 | 11.87 | -2.5 |
Nippon India Pharma Fund Direct IDCW- Latest Dividends
Record DateDividend %Bonus
03-Feb-20261200
Nippon India Pharma Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.55 | 5906349 | 1,049.97 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.73 | 625754 | 611.98 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.21 | 4095054 | 564.66 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.16 | 2783991 | 559.86 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.13 | 4118506 | 556.82 |
| Equity | Apollo Hospitals | Healthcare Services | 5.10 | 548795 | 463.62 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 4.40 | 1603562 | 399.73 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 4.04 | 2355745 | 366.90 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.53 | 913918 | 320.67 |
| Equity | Max Healthcare | Healthcare Services | 3.31 | 3498082 | 300.83 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.90 | 1364742 | 263.09 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.83 | 1029460 | 256.77 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.73 | 800549 | 247.84 |
| Equity | Vijaya Diagnost. | Healthcare Services | 2.66 | 1671618 | 241.66 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 2.61 | 9937272 | 237.41 |
| Equity | Medplus Health | Retailing | 2.26 | 3545229 | 205.58 |
| Equity | Fortis Health. | Healthcare Services | 2.25 | 2656299 | 204.04 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.22 | 78546 | 201.35 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.10 | 1000578 | 190.75 |
| Equity | Thyrocare Tech. | Healthcare Services | 1.93 | 3837967 | 175.12 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.82 | 323678 | 165.51 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.56 | 823911 | 141.72 |
| Equity | Syngene Intl. | Healthcare Services | 1.55 | 3501497 | 141.00 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 1.42 | 766774 | 128.92 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.36 | 3896349 | 123.26 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.32 | 640910 | 119.96 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.30 | 1420040 | 117.69 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.29 | 318249 | 117.36 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 1.09 | 1351672 | 98.90 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.06 | 300272 | 96.21 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 0.97 | 2504071 | 88.09 |
| Equity | Natco Pharma | Pharmaceuticals & Biotechnology | 0.90 | 1040000 | 81.36 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 0.81 | 213659 | 73.54 |
| Equity | Molbio Diagnosti | Healthcare Equipment & Supplies | 0.53 | 380293 | 48.44 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.46 | 66230 | 42.15 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.38 | 1651628 | 34.40 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.15 | 111738 | 13.91 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
8,03,520.11
Trustee/s:
NA
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
NA
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
